Peripheral Neuropathy Trial, Recruiting NCT06330181 Sponsor: Texas A&M University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06330181
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had an incomplete spinal cord injury (meaning some function remains below the injury site) affecting the lower back, legs, or lower neck area (specifically C5 to C7 levels)
  • People who experience nerve pain every day at a level of at least 4 out of 10 in severity, lasting for 3 or more months
  • People who answer "yes" to more than 2 questions on a specific 7-question spinal cord injury pain assessment tool called the SCIPI
  • People who are 18 years of age or older
  • People who are at least one and a half years past the time of their spinal cord injury before the study begins (screening may happen earlier)
  • People who have a mobile phone with a working and usable signal
  • People who have been on a stable pain medication routine for at least one month
  • People who are cleared as suitable for physical activity based on a specific safety scale called the VRWalk
  • People who do not experience motion sickness that interferes with daily life
  • People who use a wheelchair for at least 75% of their time

Who may not be able to join:

  • People whose spinal cord injury is at the C1 to C4 level (upper neck)
  • People under the age of 18
  • People who were injured less than one year ago
  • People who are not able to understand spoken English
  • People who are currently in prison
  • People who are blind
  • People who experience severe motion sickness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 804-569-5965

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Texas A&M University
Registry
ClinicalTrials.gov
Start date
2 December 2024
Est. completion
1 January 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Pain Intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov